ADVERTISEMENT
Search
Login JOIN / RENEW

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Opioid taper and overdose risk: What pharmacists should know Opioid taper and overdose risk: What pharmacists should know

Opioid taper and overdose risk: What pharmacists should know

0 28621
In the ongoing aftermath of the opioid crisis, it’s common for physicians to attempt to wean some patients off opioids in favor of alternative means of pain management. But while the goal is increased safety for the patient, opioid tapering does not come without risks. A recent study in JAMA found a significant association between opioid...
American Pharmacists Month: You stand by us all American Pharmacists Month: You stand by us all

American Pharmacists Month: You stand by us all

As we reach the midpoint of American Pharmacists Month, we must continuously honor the pharmacists who do heroic work every day in the face of...
0 6759
New impurities lurking in some heart medications New impurities lurking in some heart medications

New impurities lurking in some heart medications

Over the past few years, blood pressure medications have been recalled due to concerns about N-nitrosodimethylamine (NDMA), a probable carcinogen....
0 29568
APhA members unite to advocate for pharmacy patients APhA members unite to advocate for pharmacy patients

APhA members unite to advocate for pharmacy patients

APhA members representing 31 states, Puerto Rico, and the District of Columbia gathered last week to flex their political muscles at the...
0 27192

Walmart–Novo Nordisk insulin offers deep discounts to select few

Early last summer, Walmart announced the launch of a new private brand, cash-pay analog insulin, made by drug manufacturer Novo Nordisk. Sold under Walmart’s private ReliOn label, vials go for $72.88 each and FlexPens for $85.88 each. Walmart calculates that the products will save customers between 58% and 75% of the cash price for branded analog insulin products, which translates to...
123456789
ADVERTISEMENT